| Terminated | Post-Treatment Follow-up Study for Liver Disease Subjects With or Without Cirrhosis After Receiving Emricasan Liver Diseases, Liver Fibrosis, Liver Cirrhosis | — | 2018-02-27 |
| Unknown | Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis Decompensated Cirrhosis | Phase 2 | 2017-06-28 |
| Completed | Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis Non-alcoholic Steatohepatitis, Fibrosis, Liver Diseases | Phase 2 | 2016-01-26 |
| Completed | A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension Liver Cirrhosis, Hepatic Cirrhosis, Portal Hypertension | Phase 2 | 2014-08-01 |
| Completed | A Study of IDN-6556 in Subjects With Liver Cirrhosis Liver Cirrhosis, Hepatic Cirrhosis | Phase 2 | 2014-08-01 |
| Completed | A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV Liver Fibrosis, Hepatic Fibrosis, Liver Cirrhosis | Phase 2 | 2014-05-01 |
| Completed | PK and PD Study of IDN-6556 in Subjects With Hepatic Impairment and Matched Healthy Volunteers Hepatic Impairment, Liver Diseases, Digestive System Diseases | Phase 1 | 2014-04-01 |
| Completed | A Study of IDN-6556 in Subjects With NAFLD and Raised Transaminases Nonalcoholic Steatohepatitis, Non-alcoholic Fatty Liver Disease | Phase 2 | 2014-03-01 |
| Completed | PK and PD Study of IDN-6556 in Subjects With Severe Renal Impairment and Matched Healthy Volunteers Renal Impairment, Renal Insufficiency, Kidney Disease | Phase 1 | 2014-01-01 |
| Terminated | Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF Acute on Chronic Hepatic Failure, Acute Liver Failure, Liver Cirrhosis | Phase 2 | 2013-09-01 |
| Terminated | Study of IDN-6556 in Patients With Severe Alcoholic Hepatitis and Contraindications to Steroid Therapy Alcoholic Hepatitis | Phase 2 | 2013-07-01 |
| Terminated | Standard of Care (SOC) With or Without CTS-1027 in Hepatitis C (HCV) Null-Responders Hepatitis C | Phase 2 | 2011-01-01 |
| Completed | Study of CTS-1027 in Combination With Pegylated Interferon and Ribavirin in Hepatitis C Virus (HCV) Null-Respo Hepatitis C | Phase 2 | 2010-01-01 |
| Completed | CTS-1027 in Interferon-Naive Hepatitis C Patients Hepatitis C | Phase 2 | 2009-06-01 |
| Completed | Study of CTS-1027 in Hepatitis C Patients Chronic Hepatitis C Virus Infection | Phase 2 | 2007-12-01 |
| Completed | A Caspase Inhibitor in Chronic Hepatitis C (HCV) Patients Hepatitis C, Chronic | Phase 2 | 2004-07-01 |
| Completed | Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation Liver Transplantation, Hepatitis, Cholestasis | Phase 2 | 2003-11-01 |